There has been some buying and selling insider activity on GP Strategies Corporation Commo (NYSE:GPX) recently. Samuel D. Robinson, Director disclosed the purchase of 9,294 shares of GPX stock. The shares sold for $24.47. The Director now owns $86,289,001 of the stock according to the SEC filing. Today Deborah Ung, Sr VP disclosed the sale of 1,164 shares. The shares were sold on August 16th for an average price of $24.55. Ung now owns $280,729 of the stock per the Form 4 SEC filing.
A. Marvin Strait, Director bought $33,825 worth of shares at an average price of $22.55 on August 2nd. Strait now owns $674,989 of stock per an SEC filing yesterday.
Here are a few additional firms who have increased or decreased their stake in (GPX). As of quarter end Royal Bank Of Canada had sold a total of 591,126 shares trimming its position 66.4%. The value of the company’s investment in GP Strategies Corporation Commo decreased from $24,408,000 to $6,500,000 a change of 73.4% since the last quarter. Cove Street Capital, LLC divested its stake by shedding 592,340 shares a decrease of 78.8% from 12/31/2015 to 06/30/2016. Cove Street Capital, LLC claims 159,500 shares with a value of $3,460,000. The value of the position overall is down by 81.7%.
Schwab Charles Investment Management Inc added to its ownership by buying 2,860 shares an increase of 5.1% as of 06/30/2016. Schwab Charles Investment Management Inc currently owns 59,062 shares worth $1,282,000. The total value of its holdings decreased 9.2%. Wellington Management Group Llp expanded its position by buying 67,500 shares an increase of 34.5%. Wellington Management Group Llp owns 263,434 shares valued at $5,714,000. The total value of its holdings increased 6.4%.
On February 26 the company was upgraded from “Neutral” to “Buy” in a report from B. Riley. Equity analyst Roth Capital both upgraded the stock and raised the price target on October 29 changing the price objective from $27.00 to $32.00 and altering the rating from “Neutral” to “Buy”.
On October 29 the stock rating was upgraded to “Buy” from “Neutral” and a price target of $32.00 was set in an announcement from Roth Capital. Roth Capital lowered the price target and downgraded the stock on August 3 changing the price target from $35.00 to $27.00 and moving the rating from “Buy” to “Neutral”.
On August 3 the company was downgraded from “Buy” to “Neutral” with a current price target of $27.00 in a report issued by Roth Capital. On May 6 the stock rating was upgraded to “Buy” from “Neutral” with a current price target of $35.00 in a statement from Roth Capital.
The company is so far trading up since yesterday’s close of $24.42. Shares of the company are trading at $24.67 which is slightly above $24.23, the 50 day moving average and a tad higher than the 200 day moving average of $23.85. The 50 day moving average was up $0.44 and the 200 day average went up $0.82 or +3.43%.
The most current P/E ratio is 22.41 and market cap is 410.19M. In the latest earnings report the EPS was $1.10 and is estimated to be $1.19 for the current year with 16,627,000 shares outstanding. Next quarter’s EPS is forecasted at $0.39 with next year’s EPS projected to be $1.47.